Ex Vivo Immunotherapy

· Shenzhen Zhongxing Yangfan Biotech Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ex Vivo Immunotherapy, covering 2008-11-11 to 2016-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Ex Vivo Immunotherapy for Hyperglycemia in Type 2 Diabetes Mellitus [Phase 1]